What were OneSource Specialty Pharma Ltd's latest quarterly results?
OneSource Specialty Pharma Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: -29.0%
- Revenue Growth YoY: -26.2%
- Operating Margin: 6.0%
OneSource Specialty Pharma Ltd: Stock Analysis & Fundamentals
Updated this weekOneSource Specialty Pharma Ltd (Pharma - API & CRAMS) — fundamental analysis, earnings data, and key metrics. PE: 543.0. ROE: 3.3%. This stock is not currently in the Nifty 500 momentum outperformers list.
What's Happening
📊Debt increased 68% YoY — leverage rising
👔Promoter stake down 4.5% this quarter
🌐FII stake increased 0.9% this quarter
Key Numbers
Current Price
₹1,447
Market Cap
16.6K Cr
Valuation
N/AOther Top Pharma - API & CRAMS Stocks Beating Nifty 500
Frequently Asked Questions: OneSource Specialty Pharma Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is OneSource Specialty Pharma Ltd's current PE ratio?
OneSource Specialty Pharma Ltd's current PE ratio is 543.0x.
- Current PE: 543.0x
- Market Cap: 16.6K Cr
What is OneSource Specialty Pharma Ltd's price-to-book ratio?
OneSource Specialty Pharma Ltd's price-to-book ratio is 2.8x.
- Price-to-Book (P/B): 2.8x
- Book Value per Share: ₹515
- Current Price: ₹1447
Is OneSource Specialty Pharma Ltd a fundamentally strong company?
OneSource Specialty Pharma Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 6.0%
Is OneSource Specialty Pharma Ltd debt free?
OneSource Specialty Pharma Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹1,000 Cr
What is OneSource Specialty Pharma Ltd's return on equity (ROE) and ROCE?
OneSource Specialty Pharma Ltd's return ratios over recent years
- FY2023: ROCE -12.0%
- FY2024: ROCE -12.0%
- FY2025: ROCE 6.0%
Is OneSource Specialty Pharma Ltd's cash flow positive?
OneSource Specialty Pharma Ltd's operating cash flow is negative (FY2025).
- Cash from Operations (CFO): ₹-68 Cr
- Free Cash Flow (FCF): ₹-269 Cr
What is OneSource Specialty Pharma Ltd's dividend yield?
OneSource Specialty Pharma Ltd currently does not pay a significant dividend (yield 0.00%).
- Dividend Yield: 0.00%
- Current Price: ₹1447
Who holds OneSource Specialty Pharma Ltd shares — promoters, FII, DII?
OneSource Specialty Pharma Ltd's shareholding pattern (Dec 2025)
- Promoters: 29.9%
- FII (Foreign): 19.2%
- DII (Domestic): 18.8%
- Public: 32.0%
Is promoter holding increasing or decreasing in OneSource Specialty Pharma Ltd?
OneSource Specialty Pharma Ltd's promoter holding has increased recently.
- Current Promoter Holding: 29.9% (Dec 2025)
- Previous Quarter: 29.8% (Sep 2025)
- Change: +0.16% (increasing — positive signal)
Is OneSource Specialty Pharma Ltd a new momentum entry or an established outperformer?
OneSource Specialty Pharma Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is OneSource Specialty Pharma Ltd worth studying for long term investment?
Based on quantitative research signals, here is why OneSource Specialty Pharma Ltd may be worth studying
- Currently showing mixed signals — monitor for clearer trend confirmation
What is the investment thesis for OneSource Specialty Pharma Ltd?
OneSource Specialty Pharma Ltd investment thesis summary:
What is the future outlook for OneSource Specialty Pharma Ltd?
OneSource Specialty Pharma Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.